IVFNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
INVO Fertility, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.60+0.04 (+7.78%)
Close on Oct 19, 2026
- Market cap
- $1.56M
- P/E (TTM)
- –
- Dividend yield
- –
INVO Fertility, Inc. revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | Q2 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fertility Clinic Services [Member] | $2.17M | $1.98M | $1.55M | $1.72M | $1.83M | $1.69M | $1.42M | $1.81M | $1.54M | – | – | – | 99.6% | +18.3% |
| INVOcell Device [Member] | $7.70K | $44.99K | $45.63K | $54.37K | $31.56K | $8.17K | $19.64K | $43.68K | $39.09K | – | – | – | 0.4% | -75.6% |
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | Q2 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue From External Customers [Member] | $2.18M | $2.02M | $1.58M | $1.76M | $1.86M | $1.69M | $1.43M | $1.84M | $1.58M | – | – | – | 100.0% | +16.7% |
| Clinic Revenue [Member] | $2.17M | $1.98M | $1.55M | $1.72M | $1.83M | $1.69M | $1.42M | $1.81M | $1.54M | $1.36M | $947.89K | $254.36K | 99.6% | +18.3% |
| Product [Member] | $7.70K | $32.99K | $38.13K | $34.87K | $31.56K | – | $15.14K | $28.68K | $39.09K | $18.82K | $27.00K | $61.54K | 0.4% | -75.6% |
| Inter Segment Revenue [Member] | $2.38K | $12.00K | $7.50K | $6.00K | $9.00K | $9.50K | $4.50K | – | – | – | – | – | 0.1% | -73.6% |
By region
From the segment and revenue-disaggregation notes of INVO Fertility's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.